Through the use of recombinant DNA technology, E.coli can be used for the production of human insulin. The biosynthesis of insulin within the human body confers a significant advantage over bovine or porcine synthesis, which are often immunogenic in diabetic patients[1]
Biofuels
edit | This is a user sandbox of Szymmyd. You can use it for testing or practicing edits. This is not the sandbox where you should draft your assigned article for a dashboard.wikiedu.org course. To find the right sandbox for your assignment, visit your Dashboard course page and follow the Sandbox Draft link for your assigned article in the My Articles section. |
- ^ Keefer, Linda M.; Piron, Marie-Agnes; De Meyts, Pierre (1981). "Human insulin prepared by recombinant DNA techniques and native human insulin interact identically with insulin receptors" (PDF). Proceedings of the National Academy of Sciences USA. 78: 1391–1395 – via NCBI.